vs
Side-by-side financial comparison of Resolute Holdings Management, Inc. (RHLD) and Viridian Therapeutics, Inc.\DE (VRDN). Click either name above to swap in a different company.
Resolute Holdings Management, Inc. is the larger business by last-quarter revenue ($117.7M vs $70.6M, roughly 1.7× Viridian Therapeutics, Inc.\DE). Resolute Holdings Management, Inc. runs the higher net margin — -1.5% vs -49.0%, a 47.6% gap on every dollar of revenue. Resolute Holdings Management, Inc. produced more free cash flow last quarter ($189.2M vs $-84.7M).
Resolute Mining Limited is an Australian mining corporation focused on mining operations in Africa. It is currently operating two gold mines: the Syama Gold Mine in Mali and the Mako Gold Mine in Senegal.
Viridian Therapeutics is a clinical-stage biotechnology firm developing novel disease-modifying therapies for rare, serious autoimmune and inflammatory diseases. Its lead pipeline candidate targets thyroid eye disease, a debilitating orbital disorder, with primary market focus on North America and Europe.
RHLD vs VRDN — Head-to-Head
Income Statement — Q4 FY2025 vs Q3 FY2025
| Metric | | |
|---|---|---|
| Revenue | $117.7M | $70.6M |
| Net Profit | $-1.7M | $-34.6M |
| Gross Margin | 55.7% | — |
| Operating Margin | 30.2% | -56.7% |
| Net Margin | -1.5% | -49.0% |
| Revenue YoY | — | 81958.1% |
| Net Profit YoY | — | 54.9% |
| EPS (diluted) | $-0.20 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $117.7M | — | ||
| Q3 25 | $120.9M | $70.6M | ||
| Q2 25 | $119.6M | — | ||
| Q1 25 | $103.9M | — |
| Q4 25 | $-1.7M | — | ||
| Q3 25 | $-231.0K | $-34.6M | ||
| Q2 25 | $-611.0K | — | ||
| Q1 25 | $-3.4M | — |
| Q4 25 | 55.7% | — | ||
| Q3 25 | 59.0% | — | ||
| Q2 25 | 57.5% | — | ||
| Q1 25 | 52.5% | — |
| Q4 25 | 30.2% | — | ||
| Q3 25 | 34.3% | -56.7% | ||
| Q2 25 | 34.0% | — | ||
| Q1 25 | 24.7% | — |
| Q4 25 | -1.5% | — | ||
| Q3 25 | -0.2% | -49.0% | ||
| Q2 25 | -0.5% | — | ||
| Q1 25 | -3.2% | — |
| Q4 25 | $-0.20 | — | ||
| Q3 25 | $-0.03 | — | ||
| Q2 25 | $-0.07 | — | ||
| Q1 25 | $-0.39 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $205.5M | $490.9M |
| Total DebtLower is stronger | $169.8M | — |
| Stockholders' EquityBook value | $6.5M | $503.0M |
| Total Assets | $333.4M | $577.1M |
| Debt / EquityLower = less leverage | 26.03× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $205.5M | — | ||
| Q3 25 | $148.0M | $490.9M | ||
| Q2 25 | $99.9M | — | ||
| Q1 25 | $71.0M | — |
| Q4 25 | $169.8M | — | ||
| Q3 25 | $173.4M | — | ||
| Q2 25 | $177.1M | — | ||
| Q1 25 | $180.7M | — |
| Q4 25 | $6.5M | — | ||
| Q3 25 | $10.8M | $503.0M | ||
| Q2 25 | $9.6M | — | ||
| Q1 25 | $8.9M | — |
| Q4 25 | $333.4M | — | ||
| Q3 25 | $293.2M | $577.1M | ||
| Q2 25 | $253.3M | — | ||
| Q1 25 | $214.3M | — |
| Q4 25 | 26.03× | — | ||
| Q3 25 | 16.01× | — | ||
| Q2 25 | 18.42× | — | ||
| Q1 25 | 20.38× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $196.1M | $-84.6M |
| Free Cash FlowOCF − Capex | $189.2M | $-84.7M |
| FCF MarginFCF / Revenue | 160.8% | -120.1% |
| Capex IntensityCapex / Revenue | 5.8% | 0.2% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $313.2M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $196.1M | — | ||
| Q3 25 | $59.6M | $-84.6M | ||
| Q2 25 | $48.9M | — | ||
| Q1 25 | $18.4M | — |
| Q4 25 | $189.2M | — | ||
| Q3 25 | $58.6M | $-84.7M | ||
| Q2 25 | $47.5M | — | ||
| Q1 25 | $17.8M | — |
| Q4 25 | 160.8% | — | ||
| Q3 25 | 48.5% | -120.1% | ||
| Q2 25 | 39.7% | — | ||
| Q1 25 | 17.1% | — |
| Q4 25 | 5.8% | — | ||
| Q3 25 | 0.8% | 0.2% | ||
| Q2 25 | 1.2% | — | ||
| Q1 25 | 0.6% | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
